Biotech Buzz - The Next Buyouts?
M2 Presswire, March, 2004
 | Content provided in partnership with |  |
M2 PRESSWIRE-2 March 2004-StreetInsider.com Inc.: Biotech Buzz - The Next Buyouts?(C)1994-2004 M2 COMMUNICATIONS LTD RDATE:03012004 StreetInsider.com's New Featured Article 'Biotech Buzz - The Next Buyouts?' 03/01/04: Schering-Plough (NYSE: SGP), Teva (Nasdaq: TEVA), Sicor (Nasdaq: SCRI), Pfizer (NYSE: PFE), Esperion (Nasdaq: ESPR), Invitrogen (Nasdaq: IVGN) Biotech Buzz - The Next Buyouts? Picture this (and profit from it): Big pharma, with a fistful of cash but a lean pipeline, sets out to satisfy its insatiable appetite for new products.
- Most Popular Articles in News
- The Ten Best Laptop bags
- Tata plans cheapest-ever car for Indian market
- GLOBALIZATION AND THE DEVELOPMENT OF UNDERDEVELOPMENT OF THE THIRD WORLD
- Corn is good for you; Corn is not only a tasty treat, but also a cereal that ...
- THE 50 BEST STYLISH HANDBAGS TO CARRY
- More »
It eyes its prey: small biotech ...
Read the rest of this article with a Free Trial at HighBeam Research.Find Research Guides for:
Find Featured Titles for: Health
- AAACN Viewpoint
- ABNF Journal, The
- AIDS Treatment News
- AMAA Journal
- Aboriginal Nurse, The
- Adolescence
- Adolescent Psychiatry
- Advances in Skin & Wound Care
- Age and Ageing
- Alabama Nurse
- Alberta RN
- Alcohol Research & Health
- Alternative Medicine Review
- American Family Physician
- American Fitness
- Men's Fitness
- Psychology Today
- Shape